IHH Healthcare - CGS-CIMB Research 2023-08-30: Continues To Focus On Growth

• IHH Healthcare (SGX:Q0F)'s 1H23 core net profit of RM776.7m (ex. deferred tax expenses) was below expectations at 43.6%/46.3% of our/consensus FY23F estimates.
• Although IHH’s adoption of the Malaysian Financial Reporting Standard (MFRS) 129 in 2Q22 to account for the classification of Turkey as a hyperinflationary environment led to volatility to its profitability, we observe a much a lower impact on IHH’s 2Q23 reported net profit of RM301.8m from exceptional items (EI) of a negative RM13.2m compared to the positive RM294.6m EI recognised in 2Q22.
• - Read this at SGinvestors.io -
• - Read this at SGinvestors.io -

Hospital and Healthcare operational statistics at a glance

• Read more at SGinvestors.io.

Above is the excerpt from research report by CGS-CIMB.
Clients of CGS-CIMB may access the full report in PDF @ https://www.itradecimb.com.sg/.

Read also CGS-CIMB's most recent report:
2023-12-02 IHH Healthcare - Scope For Better Profitability.

Previous report by CGS-CIMB:
2023-12-01 IHH Healthcare - An All-Around Improvement In 3Q23.

Price targets by 3 other brokers at IHH Healthcare Target Prices.

Listing of research reports at IHH Healthcare Analyst Reports.

Relevant links:
IHH Healthcare Share Price History,
IHH Healthcare Announcements,
IHH Healthcare Dividend Payout Dates & Corporate Actions,
IHH Healthcare News